Skip to main content
. 2013 Dec 2;2013:548085. doi: 10.1155/2013/548085

Table 4.

The comparison of the Treg cells level between patients with SR and with non-SR.

Before the treatment (%) During the follow-up phase (%)
The rapamycin group
SR 17 5.17 ± 1.50 6.94 ± 1.40
Non-SR 8 5.5 ± 1.65 6.01 ± 1.22

The cyclosporine A group
SR 11 5.84 ± 1.82 6.07 ± 1.14
Non-SR 17 5.49 ± 1.39 5.11 ± 1.01

P < 0.005, comparing the Treg cells level before the treatment to that during the follow-up phase in the rapamycin group.